Comparison of Shape-Matching and Docking as Virtual Screening Tools

OpenEye Scientific Software, Santa Fe, New Mexico 87507, USA.
Journal of Medicinal Chemistry (Impact Factor: 5.45). 02/2007; 50(1):74-82. DOI: 10.1021/jm0603365
Source: PubMed


Ligand docking is a widely used approach in virtual screening. In recent years a large number of publications have appeared in which docking tools are compared and evaluated for their effectiveness in virtual screening against a wide variety of protein targets. These studies have shown that the effectiveness of docking in virtual screening is highly variable due to a large number of possible confounding factors. Another class of method that has shown promise in virtual screening is the shape-based, ligand-centric approach. Several direct comparisons of docking with the shape-based tool ROCS have been conducted using data sets from some of these recent docking publications. The results show that a shape-based, ligand-centric approach is more consistent than, and often superior to, the protein-centric approach taken by docking.

Download full-text


Available from: Paul C D Hawkins
  • Source
    • "Top scoring molecules were expanded using ROCS (OpenEye Scientific Software, Santa Fe, NM. (Hawkins et al., 2007) and filtered by favourable modelled binding pose, structural diversity and cLogP to yield a library of 200 compounds. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C virus (HCV) non-structural protein 2 (NS2) encodes an autoprotease activity that is essential for virus replication and thus represents an attractive anti-viral target. Recently, we demonstrated that a series of epoxide-based compounds, previously identified as potent inhibitors of the clotting factor, FXIII, also inhibited NS2-mediated proteolysis in vitro and possessed anti-viral activity in cell culture models. This suggested that a selective small molecule inhibitor of the NS2 autoprotease represents a viable prospect. In this independent study, we applied a structure-guided virtual high-throughput screening approach in order to identify a lead-like small molecule inhibitor of the NS2 autoprotease. This screen identified a molecule that was able to inhibit both NS2-mediated proteolysis in vitro and NS2-dependent genome replication in a cell-based assay. A subsequent preliminary structure-activity relationship (SAR) analysis shed light on the nature of the active pharmacophore in this compound and may inform further development into a more potent inhibitor of NS2 mediated proteolysis.
    Full-text · Article · Oct 2015 · Antiviral research
  • Source
    • "The goal of ligand–protein docking is to predict the predominant binding mode(s) of a ligand with a protein of known three-dimensional structure. Virtual screening on the basis of molecular descriptors and physicochemical properties of active ligands has great usefulness in finding hits and leads through library enrichment for screening (28), a strategy that is also well-used for reducing and enriching the library of ligands for molecular docking; there are recent reports that ligand shape-matching does as well as, if not better than, docking (29). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The urgent need of neuraminidase inhibitors (NI) has provided an impetus for understanding the structure requisite at molecular level. Our search for selective inhibitors of neuraminidase has led to the identification of pharmacophoric requirements at various positions around acyl thiourea pharmacophore. The main objective of present study is to develop selective NI, with least toxicity and drug like ADMET properties. Electronic, Steric requirements were defined using kohnone nearest neighbour- molecular field analysis (kNN-MFA) model of 3D-QSAR studies. Results generated by QSAR studies showed that model has good internal as well as external predictivity. Such defined requirements were used to generate new chemical entities which exhibit higher promising predicted activities. To check selective binding of designed NCE's docking studies were carried out using the crystal structure of the neuraminidase enzyme having co-crystallized ligand Oseltamivir. Thus, molecular modelling provided a good platform to optimize the acyl thiourea pharmacophore for designing its derivatives having potent anti-viral activity.
    Full-text · Article · Mar 2014 · Iranian journal of pharmaceutical research (IJPR)
    • "Other methods are based on the assumption that molecules with a similar shape behave similar. These shape-based methods compare the volume of molecules and have been applied successfully in virtual screening and clustering [16] [17]. Molecular scaffolds offer an alternative way to describe molecular structures in a way that is particularly close to how a chemist sees a molecule. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple factors have to be optimized in the course of a drug discovery project. Traditionally this includes potency on a single target, eventually specificity as well as the pharmacokinetic, physicochemical and the safety profile. Recently an additional dimension has been added by realizing that the therapeutic outcome of a drug is often determined not only by its activity on a single target but by its activity profile across a variety of biological targets. To address the polypharmacology of drug candidates many compounds are tested on a set of targets or in phenotypic screens generating a tremendous amount of data. To extract useful information computational methods at the interface of proteomics and cheminformatics are indispensable. This review will focus on some recent developments in this field. This article is part of a Special Issue entitled: Computational Proteomics in the Post-Identification Era.
    No preview · Article · May 2013 · Biochimica et Biophysica Acta
Show more